Series A - Synnovation Therapeutics - 2023-12-14 - Crunchbase

Synnovation Therapeutics raised $102000000 on 2023-12-14 in Series A. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. ...

CouponFollow Extension

$102000000
OFF

Series A - Synnovation Therapeutics - 2023-12-14 - Crunchbase

2 weeks from now

Synnovation Therapeutics raised $102000000 on 2023-12-14 in Series A. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. ...

crunchbase.com

$102
OFF

Synnovation Therapeutics Launches With $102 Million To

2 weeks from now

Jan 24, 2024 · WILMINGTON, Del.--(BUSINESS WIRE)-- Synnovation Therapeutics, a precision medicine company developing small molecule therapies optimized to achieve best-in-class …

biospace.com

$115
OFF

Third Rock Ventures - Recent News & Activity - Crunchbase

2 weeks from now

Nov 12, 2024 · Pulse 2.0 — Maze Therapeutics: $115 Million (Series D) ... Business Wire — Synnovation Therapeutics Launches with $102 Million to Advance Clinical-Stage ... BioSpace …

crunchbase.com

$102
OFF

Synnovation’s $102m Round Heads Latest Biotech Financings

2 weeks from now

Jan 27, 2025 · Wilmington, Delaware-based Synnovation, a specialist in small-molecule therapeutics for cancer, has emerged from the shadows with a $102 million first-round …

pharmaphorum.com

$102
OFF

Precision Medicine Company Synnovation Therapeutics Launches …

2 weeks from now

Jan 24, 2024 · Synnovation Therapeutics launches with a $102 million Series A funding round led by Third Rock Ventures, focusing on developing small molecule therapies for highly validated …

venturecapital.com

$102
OFF

Synnovation Therapeutics Launches With $102M Series A

2 weeks from now

Jan 25, 2024 · Synnovation Therapeutics Inc. has launched with a $102 million series A financing. The company's pipeline is built around highly validated precision oncologic targets, and the …

bioworld.com

$139
OFF

Synnovation Therapeutics Funding & Investors - Tracxn

2 weeks from now

Dec 2, 2024 · Synnovation Therapeutics has raised a total funding of $139M over 3 rounds from 5 investors. Investors include Third Rock Ventures, Nextech Invest and 3 others. Their latest …

tracxn.com

$139
OFF

Synnovation Therapeutics - Company Profile - Tracxn

2 weeks from now

Jan 31, 2025 · Synnovation Therapeutics. has raised a total funding of $139M over 3 rounds. ... was on Nov 24, 2021. What are the most recent funding rounds of Synnovation Therapeutics? …

tracxn.com

$102
OFF

Synnovation Therapeutics Launches With $102 Million To Advance …

2 weeks from now

Jan 25, 2024 · WILMINGTON, Del.--Synnovation Therapeutics, a precision medicine company developing small molecule therapies optimized to achieve best-in-class pharmacology against …

delawarebio.org

$102
OFF

Sirona Capital Portfolio Investments, Sirona Capital Funds, Sirona ...

2 weeks from now

Synnovation Therapeutics: Precision Medicine Company Raises $102 Million To Develop Small Molecule Therapies. Jan 25, 2024. Synnovation Therapeutics – a precision medicine company …

cbinsights.com

$24999998
OFF

Venture Round - Synnovation Therapeutics - 2023-05-24

2 weeks from now

May 24, 2023 · Synnovation Therapeutics raised $24999998 on 2023-05-24 in Venture Round ... Organization Name . Synnovation Therapeutics . Announced Date May 24, 2023; Funding …

crunchbase.com

$314
OFF

Startup Funding Regained Its Footing In 2024 As AI Became The …

2 weeks from now

Jan 7, 2025 · Global venture funding in 2024 edged above 2023’s totals, with AI showing the biggest leap in amounts year to year. Overall startup funding in 2024 reached close to $314 …

crunchbase.com

$11999775
OFF

Venture Round - Synnovation Therapeutics - 2021-11-24

2 weeks from now

Nov 24, 2021 · Synnovation Therapeutics raised $11999775 on 2021-11-24 in Venture Round. Cookie Settings | Do Not Sell or Share My Personal Info

crunchbase.com

$52000000
OFF

Series A - Deep Apple Therapeutics - 2023-12-14 - Crunchbase

2 weeks from now

Dec 14, 2023 · Deep Apple Therapeutics raised $52000000 on 2023-12-14 in Series A. Apple Tree Partners Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, …

crunchbase.com

FAQs about Series A - Synnovation Therapeutics - 2023-12-14 - Crunchbase Coupon?

When did synnovation Therapeutics close?

Synnovation Therapeutics closed its last funding round on Dec 14, 2023 from a Series A round. Who are Synnovation Therapeutics's competitors? Alternatives and possible competitors to Synnovation Therapeutics may include Carisma Therapeutics, Century Therapeutics, and Fore Biotherapeutics. ...

Why did synnovation Therapeutics invest $102 million?

Synnovation Therapeutics launched with $102 million to advance its clinical-stage pipeline of precision therapies targeting highly validated disease pathways. View contacts for Synnovation Therapeutics to access new leads and connect with decision-makers. ...

Who is synnovation Therapeutics?

Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers. It is dedicated to the discovery and development of therapeutics that can improve the lives of people with cancer. Leveraging its deep expertise in medicinal chemistry, cancer biology, and ...

What is the current valuation of synnovation Therapeutics?

The current valuation of Synnovation Therapeutics is 00000. What is Synnovation Therapeutics’s current revenue? The current revenue for Synnovation Therapeutics is 000000. How much funding has Synnovation Therapeutics raised over time? Synnovation Therapeutics has raised $139M. Who are Synnovation Therapeutics’s investors? ...

Who are the competitors of synnovation Therapeutics?

BioTheryx, Cerecin, Vividion Therapeutics, Lycia Therapeutics, and Carina Biotech are some of the 105 competitors of Synnovation Therapeutics. Discover how our experts ensure you’re getting the most accurate financial data in the industry. ...

What can Dave do for synnovation?

Dave’s broad expertise in all facets of business and corporate development will be instrumental to Synnovation’s mission to discover and develop best-in-class therapeutics that improve the lives of patients. Most recently, Dave served as Executive Director, Business Development at Incyte. ...